Search

everythinglearnresearchcommunity

for

Search:↓

Dutasteride effectively treats benign prostatic obstruction, improves urinary flow, reduces prostate size, and may prevent prostate cancer, but can cause sexual side effects.

Zapoteca portoricensis extract may help protect against prostate issues and support liver and kidney health in rats.

Dutasteride and finasteride do not significantly affect bone density, blood fats, or blood production, but slightly lower PSA levels and minimally impact sexual function in healthy young men.

Certain drugs that block specific enzymes can help treat prostate diseases.

Cinnamomi cortex may help treat prostate enlargement by reducing related proteins.

Micrografts improve hair density and thickness without side effects.

Different drugs for prostate-related urinary symptoms work but have various side effects, and treatment should be tailored to the individual.

Early hair loss may indicate prostate issues.

5 alpha-reductase inhibitors can slightly improve symptoms of enlarged prostate but have a high risk of sexual side effects.

α-spinasterol from Melandrium firmum can help reduce prostate enlargement.

Finasteride does not prevent bladder cancer.

Finasteride for hair loss is safe and does not increase the risk of high-grade prostate cancer.

Smaller finasteride particles increase effectiveness in treating hair loss.

Taking both finasteride and dutasteride for prostate issues may raise the risk of heart problems.

New steroids were effective in blocking male hormone receptors in hamster prostates.

A new compound was effective for imaging prostate cancer in rats.

Genetic differences within ethnic groups may affect prostate cancer treatment effectiveness.

Baldness, especially at the front, may lower the risk of testicular cancer by 31%, but its link to prostate cancer is unclear.

Flutamide and a new synthetic steroid affected brain and prostate chemicals and showed potential for treating androgen-related conditions and epilepsy.

Thermobalancing therapy is safe and effective for treating enlarged prostates.

COVID-19 may worsen symptoms of benign prostatic hyperplasia (BPH).

Extracellular vesicles and androgen receptors may help identify prostate cancer resistance and reduce SARS-CoV-2 infection.

Finasteride reduces prostate size and PSA levels in young patients.

Men with early hair loss may have a higher risk of enlarged prostate and possibly prostate cancer due to shared hormonal factors.

The research found that androgens help control blood flow in the rat prostate through a specific binding site.

Finasteride reduces prostate cancer risk but may increase high-grade tumors and has side effects; biopsy methods have similar outcomes; psychosocial factors affect sexual recovery post-surgery.

Combining D-004 and finasteride is more effective at reducing prostate enlargement than using either alone.

Antiandrogen drugs can reduce PSA levels in women with excess hair, suggesting PSA is a sign of male hormone activity in women.

Higher DHT in male baldness may protect against prostate cancer.

5-Alpha reductase inhibitors may prevent prostate cancer but are not widely used due to concerns about trial relevance and potential risks, and more research is needed to confirm long-term benefits.